Correlation Between Bristol Myers and Amgen

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Amgen Inc, you can compare the effects of market volatilities on Bristol Myers and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Amgen.

Diversification Opportunities for Bristol Myers and Amgen

0.37

Correlation Coefficient

Bristol Myers  Amgen

Weak diversification

The 3 months correlation between Bristol and Amgen is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Bristol Myers i.e., Bristol Myers and Amgen go up and down completely randomly.

Pair Corralation between Bristol Myers and Amgen

Assuming the 90 days trading horizon Bristol Myers is expected to generate 3.3 times less return on investment than Amgen. But when comparing it to its historical volatility, Bristol Myers Squibb is 1.08 times less risky than Amgen. It trades about 0.06 of its potential returns per unit of risk. Amgen Inc is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  528,827  in Amgen Inc on December 30, 2024 and sell it today you would earn a total of  114,173  from holding Amgen Inc or generate 21.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Amgen Inc

Bristol Myers Squibb

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Bristol Myers is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Amgen Inc

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Amgen showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Amgen

The main advantage of trading using opposite Bristol Myers and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.

The idea behind Bristol Myers Squibb and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.